Workflow
MiMedx(MDXG) - 2025 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to_ Commission File Number 001-35887 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 MIMEDX GROUP, INC. For the Quarterly Period Ended September 30, 2025 OR (Exact name of registrant as specified in its charter) Florida 26-2 ...